On the mode of action of lipid-lowering agents. VII. In vivo inhibition and reversible binding of hepatic acetyl coenzyme A carboxylase by hypolipidemic drugs.
D000645:Ammonium Sulfate; D000818:Animals; D001639:Bicarbonates; D001835:Body Weight / Q000187:drug effects; D002247:Carbon Isotopes; D011232:Chemical Precipitation; D002713:Chlorine / Q000494:pharmacology; D003065:Coenzyme A; D003956:Dialysis; D004041:Dietary Fats; D004789:Enzyme Activation; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008025:Ligases / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D008099:Liver / Q000033:anatomy & histology / Q000201:enzymology*; D009281:Naphthalenes / Q000494:pharmacology*; D009929:Organ Size; D010636:Phenols / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology*; D011485:Protein Binding; D051381:Rats; D012737:Sex Factors; D013997:Time Factors
D001639:Bicarbonates; D002247:Carbon Isotopes; D004041:Dietary Fats; D000960:Hypolipidemic Agents; D009281:Naphthalenes; D010636:Phenols; D011422:Propionates; D002713:Chlorine; D008025:Ligases; D003065:Coenzyme A; D000645:Ammonium Sulfate